Clostridium difficile infection, short history, evolution from hospital hallways to community- acquired infection

1 Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis. 1994;18(suppl 4):S265–S272. Search in Google Scholar

2 Hall IC, O’Toole E: Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilis, Am J Dis Child, 1935, vol. 49 (pg. 390-402) Search in Google Scholar

3 Smith LDS, King EO. Occurrence of Clostridium difficile in infections of man, J Bacteriol, 1962, vol. 84 (pg. 65-7) Search in Google Scholar

4 Green RH. The association of viral activation with penicillin toxicity in guinea pigs and hamsters, Yale J Biol Med, 1974, vol. 47 (pg. 166-81) Search in Google Scholar

5 Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis: a prospective study, Ann Intern Med, 1974, vol. 81 (pg. 429-33) Search in Google Scholar

6 Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978 May 20;1(8073):1063-6. doi: 10.1016/s0140-6736(78)90912-1. PMID: 77366. Search in Google Scholar

7 Paul A. Lawson, Diane M. Citron, Kerin L. Tyrrell, Sydney M. Finegold, Reclassification of Clostridium difficile as Clostridioides difficile. Anaerobe, Volume 40, 2016, Pages 95-99, ISSN 1075-9964 Search in Google Scholar

8 Editorial: C difficile- a rose by any other name. The Lancet Infectious Disease. 2019 May. Volume 19, Issue 5, p449 Search in Google Scholar

9 McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short - stay hospitals. Emerg Infect Dis. 2006;12:409–415. Search in Google Scholar

10 Cohen SH, Gerding DN, Johnson S: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infect Control Hosp Epidemiol201031543145520307191 Search in Google Scholar

11 Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: New developments in epidemiology and pathogenesis. Nature Reviews Microbiology. 2009;7:526–536. Search in Google Scholar

12 CDC- 2019 Annual Report for the Emerging Infections Program for Clostridioides difficile Infection Search in Google Scholar

13 Guh AY et al: Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med 2020;382:1320-1330 Search in Google Scholar

14 Finn, E., Andersson, F.L. & Madin-Warburton, M. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis 21, 456 (2021). Search in Google Scholar

15 Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173: 2039–2046. Search in Google Scholar

16 Buddle JE, Fagan RP. Pathogenicity and virulence of Clostridioides difficile. Virulence. 2023 Dec;14(1):2150452. doi: 10.1080/21505594.2022.2150452. PMID: 36419222; PMCID: PMC9815241 Search in Google Scholar

17 Warny M, Pepin J, Fang A: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 36694911079108416182895 Search in Google Scholar

18 Goorhuis A, Bakker D, Corver J: Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 4791162117018808358 Search in Google Scholar

19 Smith AB, Soto Ocana J, Zackular JP 2020. From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis. Infect Immun 88:10.1128/iai.00934-19. Search in Google Scholar

20 Schwartz O et al: Characterization of community-acquired Clostridioides difficile strains in Israel, 2020–2022. Front. Microbiol., 19 December 2023. Sec. Infectious Agents and Disease. Volume 14 - 2023 Search in Google Scholar

21 Juneau C, Mendias EN, Wagal N, Loeffelholz M, Savidge T, Croisant S, Dann S. Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications. J Nurse Pract. 2013 Jan;9(1):1-6. doi: 10.1016/j.nurpra.2012.10.007. PMID: 23814528; PMCID: PMC3694783. Search in Google Scholar

22 Ogielska M et al: Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature. International Journal of Infectious Diseases, Volume 37, 2015, Pages 36-41. ISSN 1201-9712, Search in Google Scholar

23 Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ: Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45899299817879913 Search in Google Scholar

24 Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therapeutic Advances in Gastroenterology. 2021;14. doi:10.1177/17562848211016248 Search in Google Scholar

25 Al Saif N, Brazier JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133–7. Search in Google Scholar

26 Marsh JW. Counterpoint: is Clostridium difficile a food-borne disease? Anaerobe. 2013;21:62–3. Search in Google Scholar

27 Thornton, C.S., Rubin, J.E., Greninger, A.L. et al. Epidemiological and genomic characterization of community-acquired Clostridium difficile infections. BMC Infect Dis 18, 443 (2018). https://doi.org/10.1186/s12879-018-3337-9 Search in Google Scholar